Skip to main content
Fig. 10 | BMC Medical Genomics

Fig. 10

From: COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing

Fig. 10

Correlation between COL5A2 expression and sensitivity to immunotherapy. a-d The IPS in high and low expression groups of COL5A2. e Comparison of COL5A2 expression between responders and non-responders to immunotherapy in PRJEB25780 cohort. f ROC curve for COL5A2 expression in predicting response to immunotherapy. **p < 0.01; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us